Abstract:Adipsic arginine vasopressin deficiency(aAVP-D) is a rare, high-risk syndrome, particularly difficult to recognize and manage in children and adolescents. This investigation examined the clinical features and management of aAVP-D in children and adolescents with sellar germ cell tumors (GCTs). A retrospective survey was performed on 260 patients with sellar GCTs, categorized into aAVP-D and non-aAVP-D groups based on thirst presence. General characteristics, hypothalamic syndrome, pituitary function, metabolic indicators, and complications were compared. Biochemical indicator changes in the aAVP-D group were analyzed after systematic management, and receiver operating characteristic (ROC) curve analysis established the optimum serum sodium cut-off for predicting the aAVP-D. 25 patients (9.6%) developed aAVP-D. The aAVP-D group had larger tumors with hypothalamic involvement and more surgical resections. They also demonstrated more hypothalamic syndrome, central adrenal insufficiency, central hypogonadism, and insulin-like growth factor-1 levels below norms. Furthermore, aAVP-D patients exhibited significantly higher rates of hypernatremia (100% vs 20.9%, p < 0.001), hyperuricemia (60.0% vs 23.4%, p < 0.001), renal impairment (32.0% vs 1.7%, p < 0.001), and venous thrombosis (4.0% vs 0%, p = 0.002). Following systematic management, aAVP-D patients experienced significant reductions in serum sodium, uric acid, and creatinine levels, although these remained higher than in the non-aAVP-D group. ROC analysis indicated that a serum sodium level above 149.5 mmol/L predicted aAVP-D. Conclusion Patients with aAVP-D had more tumor involvement in the hypothalamic region, surgical resections, hypothalamic syndrome, hypopituitarism, and complications. Serum sodium levels above 149.5 mmol/L necessitated heightened vigilance for aAVP-D. Early identification and systematic management reduced complications, though clinical management remained challenging. What is Known • Adipsic arginine vasopressin deficiency (aAVP-D) is a rare and high-risk syndrome that is difficult to recognize and manage. • There are few reports on aAVP-D, most of which focus on adult patients. • The characteristics and management of aAVP-D in children and adolescents remain unclear. What is New • Children and adolescents with aAVP-D experienced higher rates of hypothalamic region tumor involvement, surgical resections, hypothalamic syndrome, hypopituitarism, and associated complications. • Serum sodium levels above 149.5 mmol/L necessitated heightened vigilance for aAVP-D. • Early recognition and structured management of ADI lowered the risk of complications.

Objective assessment of thirst recovery in patients with adipsic diabetes insipidus

Clinical characteristics of adipsic diabetes insipidus

Effect of Acute Water Loading on Plasma Levels of Antidiuretic Hormone AVP Aldosterone, ANP Fractional Excretion of Sodium and Plasma and Urine Osmolalities in Myxedema.

Clinical characteristics and management of adipsic arginine vasopressin deficiency in children and adolescents with sellar germ cell tumors

Desmopressin treatment in dipsogenic form of primary polydipsia: keep serum osmolality marginally below thirst threshold for symptomatic relief

Diabetes insipidus: vasopressin deficiency...

A multi-parameter study of the etiological diagnosis of hyponatremia after hypothalamic tumor surgery

Syndrome of inappropriate antidiuresis in the absence of arginine vasopressin

Syndrome of Inappropriate Antidiuretic Hormone Secretion after Cranial Cerebral Injury

INFLUENCE OF LOW-SODIUM DIET MANAGEMENT ON THIRST RESPONSE IN END STAGE RENAL DISEASE PATIENTS WITH HEMODIALYSIS

Challenging case of hypernatraemia in infancy

Efficacy and safety of selective arginine vasopressin V2 receptor antagonist for the syndrome of inappropriate antidiuretic hormone secretion

Combined central diabetes insipidus and cerebral salt wasting syndrome after traumatic brain injury

Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency

Diagnosis and Critical Care for Concurrent Central Diabetes Insipidus with Cerebral Salt-Wasting Syndrome in Traumatic Brain Injury Patients

Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD

Diagnosis and differential diagnosis of diabetes insipidus: Update

Central diabetes insipidus: a rare perioperative cause of severe hypernatraemia

Prevalence of and risk factors for thirst in the intensive care unit: An observational study

Diabetes Insipidus: Diagnosis, Pathogenesis, and Management

Clinical Analysis of 156 Cases of Diabetes Insipidus